PTX-061

N/A

Report date: 2023/06/26 09:15:47

Base Information

Drug NamePTX-061
Drug Alias NamePTX-061
ClassificationSmall molecules
Mechanisms of ActionAnti-oxidative stressChelating agents
TargetsUpdating
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPleco Therapeutics BV
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A